Gene · 6091
Papers2,184
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,184
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Advances in neovascularization after diabetic ischemia. | World J Diabetes | 2022 | 36437864 | PubTator, text mining | PubMed |
| Anticancer traits of chimeric antigen receptors (CARs)-Natural Killer (NK) cells as novel approaches for melanoma treatment. | BMC Cancer | 2022 | 36434591 | PubTator, text mining | PubMed |
| MicroRNA Expression Profile in TSC Cell Lines and the Impact of mTOR Inhibitor. | Int J Mol Sci | 2022 | 36430972 | PubTator, text mining | PubMed |
| Non-Coding RNAs in Regulating Plaque Progression and Remodeling of Extracellular Matrix in Atherosclerosis. | Int J Mol Sci | 2022 | 36430208 | PubTator, text mining | PubMed |
| Tissue-Specific Human Extracellular Matrix Scaffolds Promote Pancreatic Tumour Progression and Chemotherapy Resistance. | Cells | 2022 | 36429078 | PubTator, text mining | PubMed |
| Pan-Cancer Analysis Identifies Tumor Cell Surface Targets for CAR-T Cell Therapies and Antibody Drug Conjugates. | Cancers (Basel) | 2022 | 36428765 | PubTator, text mining | PubMed |
| Gene-edited and CAR-NK cells: Opportunities and challenges with engineering of NK cells for immunotherapy. | Mol Ther Oncolytics | 2022 | 36420307 | PubTator, text mining | PubMed |
| Harnessing natural killer cells to develop next-generation cellular immunotherapy. | Chronic Dis Transl Med | 2022 | 36420177 | PubTator, text mining | PubMed |
| SLIT2 promoter hypermethylation predicts disease progression in chronic myeloid leukemia. | Eur J Med Res | 2022 | 36411451 | PubTator, text mining | PubMed |
| Identification of risk model based on glycolysis-related genes in the metastasis of osteosarcoma. | Front Endocrinol (Lausanne) | 2022 | 36387908 | PubTator, text mining | PubMed |
| Somatic mutations of activating signalling, transcription factor, and tumour suppressor are a precondition for leukaemia transformation in myelodysplastic syndromes. | J Cell Mol Med | 2022 | 36380727 | PubTator, text mining | PubMed |
| Replication collisions induced by de-repressed S-phase transcription are connected with malignant transformation of adult stem cells. | Nat Commun | 2022 | 36376321 | PubTator, text mining | PubMed |
| Language abnormalities in schizophrenia: binding core symptoms through contemporary empirical evidence. | Schizophrenia (Heidelb) | 2022 | 36371445 | PubTator, text mining | PubMed |
| Identification of novel interferon responsive protein partners of human leukocyte antigen A (HLA-A) using cross-linking mass spectrometry (CLMS) approach. | Sci Rep | 2022 | 36371414 | PubTator, text mining | PubMed |
| miR-23b-3p, miR-124-3p and miR-218-5p Synergistic or Additive Effects on Cellular Processes That Modulate Cervical Cancer Progression? A Molecular Balance That Needs Attention. | Int J Mol Sci | 2022 | 36362337 | PubTator, text mining | PubMed |
| Dyslexia and Attention Deficit Hyperactivity Disorder Associated to a De Novo 1p34.3 Microdeletion. | Genes (Basel) | 2022 | 36360163 | PubTator, text mining | PubMed |
| A novel risk score based on immune-related genes for hepatocellular carcinoma as a reliable prognostic biomarker and correlated with immune infiltration. | Front Immunol | 2022 | 36353638 | PubTator, text mining | PubMed |
| Natural killer cells in clinical development as non-engineered, engineered, and combination therapies. | J Hematol Oncol | 2022 | 36348457 | PubTator, text mining | PubMed |
| Metabolomic, Lipidomic, Transcriptomic, and Metagenomic Analyses in Mice Exposed to PFOS and Fed Soluble and Insoluble Dietary Fibers. | Environ Health Perspect | 2022 | 36331819 | PubTator, text mining | PubMed |
| The regulatory roles of circular RNAs via autophagy in ischemic stroke. | Front Neurol | 2022 | 36330428 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6091/papers?page=18